Abstract
Twenty-one 2-(N-arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones (4a-u) were synthesized and evaluated as HIV-1 inhibitors in vitro. Among all compounds, compounds 4n and 4p displayed the potent anti-HIV-1 activities with EC50 values of 3.48 and 8.61 μg/mL, and TI values of 34.08 and > 23.22, respectively. It demonstrated that, to a series of 2-(N-arylsulfonyl-6-methylindol-3-yl)-3-aryl-1,3-thiazolidin-4-one derivatives, introduction of R2 as 4-Cl and R3 as H or 3-Cl could afford the more promising and potent compounds.
Keywords: 2-(N-Arylsulfonylindol-3-yl)-3-aryl-1, 3-thiazolidin-4-ones, Acquired immunodeficiency syndrome, Human immunodeficiency virus-1, AIDS
Letters in Drug Design & Discovery
Title:Synthesis of New 2-(N-Arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones as HIV-1 Inhibitors In Vitro
Volume: 9 Issue: 4
Author(s): Rui-Ge Yang, Liu-Meng Yang, Ya-Zhen Ke, Ning Huang, Rui Zhang, Yong-Tang Zheng, Hui Xu
Affiliation:
Keywords: 2-(N-Arylsulfonylindol-3-yl)-3-aryl-1, 3-thiazolidin-4-ones, Acquired immunodeficiency syndrome, Human immunodeficiency virus-1, AIDS
Abstract: Twenty-one 2-(N-arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones (4a-u) were synthesized and evaluated as HIV-1 inhibitors in vitro. Among all compounds, compounds 4n and 4p displayed the potent anti-HIV-1 activities with EC50 values of 3.48 and 8.61 μg/mL, and TI values of 34.08 and > 23.22, respectively. It demonstrated that, to a series of 2-(N-arylsulfonyl-6-methylindol-3-yl)-3-aryl-1,3-thiazolidin-4-one derivatives, introduction of R2 as 4-Cl and R3 as H or 3-Cl could afford the more promising and potent compounds.
Export Options
About this article
Cite this article as:
Rui-Ge Yang, Liu-Meng Yang, Ya-Zhen Ke, Ning Huang, Rui Zhang, Yong-Tang Zheng, Hui Xu , Synthesis of New 2-(N-Arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones as HIV-1 Inhibitors In Vitro, Letters in Drug Design & Discovery 2012; 9 (4) . https://dx.doi.org/10.2174/157018012799859936
DOI https://dx.doi.org/10.2174/157018012799859936 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aqueous Drug Solubility: What Do We Measure, Calculate and QSPR Predict?
Mini-Reviews in Medicinal Chemistry Human ACE-2, MCP1 and micro-RNA 146 as Novel Markers for COVID- 19 Affection and Severity
Infectious Disorders - Drug Targets Oxidative Stress and Antioxidant Potential of One Hundred Medicinal Plants
Current Topics in Medicinal Chemistry Nicotinamide Adenine Dinucleotide Based Therapeutics
Current Medicinal Chemistry Perception and Self-Medication Practices Among the General Population During the Ongoing COVID-19 Pandemic in Mangalore, India
Current Drug Safety Editorial [New Targets and New Therapeutic Agents in Human RNA Viruses (Executive Editor: Simon Litvak)]
Current Pharmaceutical Design Nitroisoxazolones Showing Diverse Chemical Behavior: A Use ful Building Block for Polyfunctionalized Systems
Current Medicinal Chemistry Outlining the Molecules Tested <i>In Vivo</i> for Chagas Disease, Malaria, and Schistosomiasis Over the Last Six Years - A Literature Review Focused on New Synthetic Drug Identities and Repurposing Strategies
Current Medicinal Chemistry Computational Models and Methods for Drug Target Prediction and Drug Repositioning
Combinatorial Chemistry & High Throughput Screening Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Synthesis and Screening of Substituted Thiosemicarbazone Derivatives: An Approach towards Novel Anticonvulsant Search
Central Nervous System Agents in Medicinal Chemistry <i>In Silico</i> Modeling of Small Molecule Carboxamides as Inhibitors of SARS-CoV 3CL Protease: An Approach Towards Combating COVID-19
Combinatorial Chemistry & High Throughput Screening Small Molecules in Treatment of Sepsis
Current Drug Targets Polymer Conjugated Gold Nanoparticles in Biomedical Applications
Current Medicinal Chemistry New Frontiers in Hydrogenase Structure and Biosynthesis
Current Chemical Biology Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review
Current Pharmaceutical Biotechnology The Role of the Tyrosine Kinase Inhibitor STI571 in the Treatment of Cancer
Current Cancer Drug Targets Antiproliferative Evaluation of N-sulfonyl-2-alkyl-six Membered Azacycles. A QSAR Study
Medicinal Chemistry The Oxygen Therapy
Current Medicinal Chemistry Chalcones and <i>Bis</i>-Chalcones Analogs as DPPH and ABTS Radical Scavengers
Letters in Drug Design & Discovery